ArticleObesity surgery2025
The Impact of Perioperative Antibiotic Prophylaxis on Surgical Site Infections in Laparoscopic Gastric Bypass Surgery: A Single Center Analysis Among 494 Patients.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPerioperative antibiotic prophylaxis (PAP) prior to laparoscopic gastric bypass surgery is still under debate due to a lack of high evidence. Thus, the study at hand aimed to find out whether this medication lowers the rate of postoperative complications or not.
methodsIn 2020, a retrospective analysis took place at Helios Hospital Berlin Buch, Germany. The data of patients who underwent laparoscopic Roux-Y gastric bypass (LRYGB) surgery between December 2019 and December 2020 were consecutively enrolled. Individuals who received a PAP (PAP +) were compared with those who did not receive this medication (PAP -). Primary objective was the rate of postoperative complications.
resultsA total of 494 patients' charts were analyzed. The mean age was 39.7 (± 12.1) years. The body mass index was on average 46.4 (± 6.5) kg/m
conclusionIn LRYGB, with linear anastomosis, PAP did not significantly reduce SSIs or complications, although a potential benefit in high-risk subgroups (e.g., smokers, patients with diabetes, or high BMI) cannot be excluded.
Indexed as
Identifiers
40926094What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.